SCI & TECH● LOW4d ago · Oct 9, 2026, 4:10 PM
Glaukos' iDose TR meets primary goal in phase 4 trial
Seeking Alpha Tech · global
Glaukos' iDose TR met its primary goal in a phase 4 trial. This indicates a routine positive development in medical research and pharmaceutical testing.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH31m agoPolice in Germany seize robot after teen girl is allegedly gropedSouth China Morning PostSCI & TECH48m agoChina ‘robot trainers’ fold clothes, wash dishes 200 times a day for up to US$900 a monthSouth China Morning PostSCI & TECH48m agoScientist records “lost” species, as the US lists fewer endangered speciesClarínSCI & TECH2h agoPsychology says it's not an illusion that time seems to pass faster between ages 60 and 70: the brain registers novelty and routine years leave fewer marks, so entire periods are compressed in memoryClarín